Niimi, Nozomi
Shiraishi, Yasuyuki
Sawano, Mitsuaki
Ikemura, Nobuhiro
Inohara, Taku
Ueda, Ikuko
Fukuda, Keiichi
Kohsaka, Shun
Funding for this research was provided by:
Japan Society for the Promotion of Science (Nos. 16KK0186, 16H05215, 18K17332, and 20H03915)
Article History
Received: 13 August 2021
Accepted: 1 April 2022
First Online: 15 April 2022
Competing interests
: Dr. Shiraishi is affiliated with an endowed department by Nippon Shinyaku Co., Ltd., Medtronic Japan Co., Ltd., and BIOTRONIK JAPAN Inc., and received research grants from the SECOM Science and Technology Foundation and the Uehara Memorial Foundation and honoraria from Otsuka Pharmaceuticals Co., Ltd. and Ono Pharmaceuticals Co., Ltd.; Dr. Kohsaka received an unrestricted research grant from the Department of Cardiology, Keio University School of Medicine, Bayer Pharmaceutical and Pfizer Japan. The other authors declare no conflicts of interest.